Founded in 1957, the Belgian Study Group for Multiple Sclerosis
is a non-profit organisation regrouping more than 170 Belgian neurologists
with an active interest in MS. BELGIAN STUDY GROUP FOR MULTIPLE SCLEROSIS Founded in 1957, the Belgian Study Group for Multiple Sclerosis
is a non-profit organisation regrouping more than 170 Belgian neurologists
with an active interest in MS. BELGIAN STUDY GROUP FOR MULTIPLE SCLEROSIS

News

BSGMS – Save the date: Saterday 3 June 2023 – Scientific meeting ‘MS and pregnancy’ – General assembly

Faculty Club – Leuven www.facultyclub.be Preliminary programme: Welcome : 9 am Morning session: keynote lectures prof. Sandra Vukusic, Lyon (France), prof. Kerstin Hellwig, Bochum (Germany), about treatment management before, during and after pregnancy dr. David Palling, Sheffield (UK), about the Sheffield experience of setting up a pregnancy clinic for patients with MS 4th speaker TBC…

Détails

Mission

The organisation’s non-profit purpose is to encourage and develop in Belgium, in cooperation with the Belgian Charcot Foundation – the foundation of public interest which it created – the study and treatment of multiple sclerosis, by means of the various scientific-research disciplines available, in particular clinical research, biology, biochemistry, electrophysiology, immunology, virology, genetics, epidemiology and anatomopathology.

The Board

Chairman: Prof Bénédicte Dubois

Vice-president: Prof Guy Laureys

Secretary: Dr Dominique Dive

Members: Dr Melissa Cambron, Dr Brigitte Capron, Dr Bernard Dachy, Dr Danny Decoo, Prof Soraya El Sankari, Dr Frederic London, Dr Gaetano Perrotta, Prof. Veronica Popescu, Prof Vincent van Pesch, Prof Bart Van Wijmeersch, Dr Barbara Willekens

Executive officer : Mrs Isabelle Bloem-Gonsette

Statuts GBESP
Statuten BSGMS

BELTRIMS

BELTRIMS (Belgian Treatment in Multiple Sclerosis) :

Le but de ce registre est de collecter des données, en situation réelle, sur la tolérance et l’efficacité des nouveaux médicaments, de détecter à court et long terme des effets secondaires inconnus ou sous-évalués et d’étudier les effets éventuels des médicaments concernés en cas de grossesse.

Het doel van het register is het verzamelen van real life data over de tolerantie en de werkzaamheid van de nieuwe behandelingen, om zo op korte en lange termijn nog niet ontdekte bijwerkingen in het licht te stellen en de eventuele effecten op zwangerschap te bestuderen.

More info

Agenda

 

 

Contact

    (*) Required fields